Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
$58.86
-0.4%
$55.98
$39.10
$60.73
$361.99M0.6183,377 shs19,161 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
-0.41%-1.47%+2.78%+3.55%+51.04%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
$58.86
-0.4%
$55.98
$39.10
$60.73
$361.99M0.6183,377 shs19,161 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
-0.41%-1.47%+2.78%+3.55%+51.04%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
2.62
Moderate Buy$58.86N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/AN/A14.28N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
$0.370.63%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/A

Insider Ownership

CompanyInsider Ownership
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/A6.15 millionN/ANot Optionable

Recent News About These Companies

These 5 Undervalued ETFs Could Be Bargains Right Now
XPH: Healthcare Dashboard For January
State Street® SPDR® S&P® Pharmaceuticals ETF
3 Undervalued ETFs to Buy Before 2026
Pharma ETF (XPH) Hits a New 52-Week High
US and UK agree zero-tariffs on pharmaceuticals
XPH: Small-Cap Pharma Turns Higher, At Long Last

New MarketBeat Followers Over Time

Media Sentiment Over Time

SPDR S&P Pharmaceuticals ETF stock logo

SPDR S&P Pharmaceuticals ETF NYSEARCA:XPH

$58.86 -0.24 (-0.41%)
As of 05/14/2026 04:10 PM Eastern

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.